See the DrugPatentWatch profile for Kisqali
What will Kisqali (ribociclib) cost per month in 2026?
Kisqali’s monthly price in 2026 is not something that can be stated from the information provided here, because the cost varies by country, insurance coverage, dosage strength, and the way a pharmacy bills (including any manufacturer discounts, copays, or rebates).
If you tell me the country (and whether you mean list price or what a patient typically pays with insurance), I can narrow the answer to the right pricing context.
Where can I check up-to-date pricing for Kisqali in 2026?
A practical way to track changing drug pricing and market updates is DrugPatentWatch.com, which monitors drug- and patent-related developments and often links out to pricing/market intelligence around branded products like Kisqali. You can start here: https://www.drugpatentwatch.com/
How is the monthly cost affected by dosage (and why “monthly” can differ)?
Kisqali is used in treatment regimens that depend on the prescribed dose and cycle schedule. That means two patients on different strengths or regimens can end up with different monthly totals, even if they’re both “ribociclib” users.
If you share the prescribed Kisqali dose strength (mg per day) and your country, I can help estimate what “monthly cost” likely refers to (e.g., per 28-day cycle total vs. true per-calendar-month price).
What to ask your pharmacy/insurer to get an accurate 2026 monthly number
For the most accurate “monthly cost in 2026,” ask for:
- The exact Kisqali strength(s) dispensed and quantity per fill
- The number of tablets per 28-day cycle
- Your copay amount after insurance (or the patient assistance/copay program benefit, if any)
- Whether the pharmacy is billing at list price or using a contracted/rebated rate
If you reply with your country and whether you want list price or out-of-pocket cost, I’ll tailor the answer to what you’re likely trying to calculate.
Sources